NMPA Approval

Naloxone Hydrochloride Injection

Approval Number

国药准字H20065694

Company青海制药有限公司

Registration Date

April 7, 2022

Previous Approval Numbers

国药准字H20065694

Drug Information

Generic Name

盐酸纳洛酮注射液

Dosage Form

注射剂

Strength

1ml:0.4mg

Drug Type

化学药品

Registration Date

April 7, 2022

Company Information

Applicant Company

Company Name青海制药有限公司

Company Address

青海省西宁市城北区祁连路469号

Manufacturing Company

Company Name青海制药有限公司

Company Address

青海省西宁市城北区祁连路469号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸纳洛酮注射液 - NMPA 批准文号 | MedPath